Creekmur Asset Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7
Closed -$681 919
2024
Q4
$681 Hold
7
﹤0.01% 708
2024
Q3
$805 Sell
7
-109
-94% -$12.4K ﹤0.01% 762
2024
Q2
$12.3K Buy
116
+10
+9% +$1K ﹤0.01% 466
2024
Q1
$10.3K Hold
106
﹤0.01% 486
2023
Q4
$10.7K Buy
+106
New +$10.2K ﹤0.01% 518

Other funds holding NVS

Creekmur Asset Management's NVS Position: Q1 2025 in Review

Creekmur Asset Management sold out of Novartis (NVS) in Q1 2025, closing a stake of 7 shares — an estimated $681 sold.

Creekmur Asset Management first reported a position in NVS in Q4 2023 and held it in 5 quarters. The position peaked at $12.3K in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVS as of Q1 2025.

  • Creekmur Asset Management reported no remaining Novartis position as of Q1 2025 after selling out during the quarter.
  • Creekmur Asset Management sold 7 Novartis shares in Q1 2025, an estimated $681.
  • Creekmur Asset Management first reported a position in Novartis in Q4 2023 and held it in 5 quarters.
  • Creekmur Asset Management's Novartis position peaked at $12.3K in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novartis as of Q1 2025.

Based on Creekmur Asset Management's 13F filing for Q1 2025, filed 5 May 2025.